XSHE
000510
Market cap1.63bUSD
Sep 30, Last price
16.85CNY
Name
Sichuan Xinjinlu Group Co Ltd
Chart & performance
P/E
—
P/S
6.58
EPS
—
Div yield, %
—
Shrs. gr., 5y
1.26%
Rev. gr., 5y
-11.04%
Revenues
1.66b
-18.53%
Net income
-230m
L+268.31%
CFO
17m
P
Dividend
Jun 15, 20180.04 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Sichuan Xinjinlu Group Co., Ltd., headquartered in Deyang, China, specializes in the production and distribution of a diverse range of industrial chlor-alkali chemicals and plastic goods for the Chinese market. Its comprehensive product offerings include both standard and specialty polyvinyl chloride (PVC) resins, caustic soda, industrial-grade hydrochloric acid, liquid chlorine, potassium hydroxide, sangla, sodium hypochlorite, sodium hydroxide, and calcium carbide. Furthermore, the company manufactures synthetic leather and film products designed for interior applications. Beyond its core manufacturing, Sichuan Xinjinlu Group provides logistical support through warehousing and various other complementary services. The company was formerly known as Sichuan Jinlu Group Co., Ltd.
Key people
Yu Cai
Chief Financial Officer · since 2024
Jinghao Cheng
Vice President, Director · since 2020
Shaowei Feng
Vice President, Secretary of the Board · since 2025
Yang Wu
Co-President, Director · since 2025
Zhenya Zhang
Vice President · since 2025
Xiangbin Liu
Executive Vice President, Director · since 2019
Jiangdong Liu
Chairman of the Board · since 2019
Lang Peng
President, Director · since 2025
Yi Yang
Director · since 2024
Yu Cao
Independent Director · since 2022
Hong Luo
Independent Director · since 2022
Tianping Ma
Independent Director · since 2021
Headquarters & legal address
四川省德阳市区泰山南路二段733号银鑫.五洲广场一期21栋22-23层
德阳市, SC 610000
CN
德阳市, SC 610000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||